Suzanne M. Jan de Beur

Author

Also Known As

Jan de Beur, Suzanne M., M. Jan De Beur, Suzanne, S M Jan De Beur, S M Jan de Beur, S. J. de Beur, S. Jan de Beur, S. M. J. De Beur, S. M. Jan De Beur, S. M. Jan de Beur, SUZANNE M. JAN DE BEUR

107

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine University of California, San Francisco Indiana University – Purdue University Indianapolis Indiana University School of Medicine

About

Suzanne M. Jan de Beur is an author at Johns Hopkins University specializing in medicine, osteoporosis, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	6.2K
2	Health Sciences	7	7	853
3	Biology	2	2	70
4	Natural Sciences	1	1	23
5	Biochemistry	1	1	23

Suzanne M. Jan de Beur

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Clinician’s Guide to Prevention and Treatment of Osteoporosis Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff, Osteoporosis International Bone DiseaseBone HealthPreventive MedicineOsteopathyMetabolic Bone Disease	2014	4K
Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity Andrew L. Folpe, Julie C. Fanburg–Smith, Steven D. Billings, The American Journal of Surgical Pathology Sinonasal HpcUrologyConventional HpcTumoral PathologyBone Morphogenic Protein	2004	639
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group Ethel S. Siris, Robert A. Adler, John P. Bilezikian, Osteoporosis International	2014	634
FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate Ann E. Bowe, Richard B. Finnegan, Suzanne M. Jan de Beur, Biochemical and Biophysical Research Communications UrologyMolecular PhysiologyRenal FunctionPhex SubstrateMedicine	2001	344
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis Karl Insogna, Karine Briot, Erik A. Imel, Journal of Bone and Mineral Research SclerostinHuman GrowthImmunologyPathologyXlh Present	2018	329
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent Theresa J. Berndt, Theodore A. Craig, Ann E. Bowe, Journal of Clinical Investigation	2003	292
Paternally Inherited Inactivating Mutations of the<i>GNAS1</i>Gene in Progressive Osseous Heteroplasia Eileen M. Shore, Jaimo Ahn, Suzanne M. Jan de Beur, New England Journal of Medicine	2002	291
Tumor-Induced Osteomalacia Suzanne M. Jan de Beur JAMA Bone DiseaseUrologyTumor-induced OsteomalaciaVitamin D MetabolismMedicine	2005	248
Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism Suzanne M. Jan de Beur, Richard B. Finnegan, John Vassiliadis, Journal of Bone and Mineral Research	2002	214
Burosumab for the Treatment of Tumor-Induced Osteomalacia Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber, Journal of Bone and Mineral Research	2020	167

Page 1